Year None2023202220212020201920182017 March 2, 2023 Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio February 14, 2023 FDA Grants June 15, 2023 PDUFA Date to Albireo for Bylvay® in Alagille Syndrome January 9, 2023 Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
March 2, 2023 Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
January 9, 2023 Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
